Ian O Ellis Selected Research

Ian O Ellis Research Topics

Disease

235	Breast Neoplasms (Breast Cancer) 12/2024 - 01/2003
138	Neoplasms (Cancer) 12/2024 - 04/2004
26	Neoplasm Metastasis (Metastasis) 11/2020 - 03/2007
19	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 04/2008
14	Carcinoma (Carcinomatosis) 01/2021 - 10/2003
11	Triple Negative Breast Neoplasms 01/2023 - 01/2007
7	Lobular Carcinoma 11/2020 - 05/2005
7	Carcinogenesis 02/2020 - 04/2008
6	Ductal Carcinoma 11/2022 - 01/2008
6	Breast Ductal Carcinoma 01/2022 - 12/2018
6	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 04/2004
5	Necrosis 01/2020 - 01/2018
4	Disease Progression 10/2019 - 06/2004
4	Genomic Instability 01/2019 - 01/2007
3	Papillary Carcinoma 08/2020 - 08/2012
3	Residual Neoplasm 11/2019 - 07/2016
3	Lymphatic Metastasis 11/2018 - 03/2015
3	Inflammation (Inflammations) 12/2015 - 01/2008
2	Melanoma (Melanoma, Malignant) 08/2020 - 04/2012
2	Margins of Excision 11/2019 - 01/2018
2	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2018 - 12/2014
2	Male Breast Neoplasms (Male Breast Cancer) 05/2017 - 01/2017
2	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2017 - 04/2016
2	Acinar Cell Carcinoma 01/2017 - 10/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 10/2014

Drug/Important Bio-Agent (IBA)

103	Proteins (Proteins, Gene)FDA Link 12/2024 - 09/2005
51	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2005
44	Estrogen ReceptorsIBA 10/2022 - 01/2005
37	Messenger RNA (mRNA)IBA 12/2024 - 01/2007
33	Phenobarbital (Luminal)FDA Link 12/2024 - 06/2004
21	Hormones (Hormone)IBA 01/2022 - 09/2005
19	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 01/2007
17	human ERBB2 proteinIBA 04/2023 - 10/2007
16	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 05/2005
14	Tamoxifen FDA LinkGeneric 09/2021 - 01/2007
13	Cadherins (E-Cadherin)IBA 01/2019 - 05/2005
12	Indicators and Reagents (Reagents)IBA 01/2019 - 04/2004
11	Trastuzumab (Herceptin)FDA Link 11/2019 - 04/2010
10	ErbB Receptors (EGF Receptor)IBA 07/2020 - 04/2004
8	Phosphotransferases (Kinase)IBA 07/2020 - 04/2012
7	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2007
7	AntibodiesIBA 05/2017 - 08/2008
7	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2017 - 03/2013
7	ParaffinIBA 01/2016 - 10/2003
6	Estrogens (Estrogen)FDA Link 11/2022 - 07/2007
6	AnthracyclinesIBA 01/2020 - 08/2012
5	Eosine Yellowish-(YS) (Eosin)IBA 12/2018 - 08/2010
4	Amino Acid Transport Systems (Amino Acid Transporter)IBA 12/2024 - 01/2018
4	Estrogen Receptor alphaIBA 11/2020 - 08/2008
4	Cyclin EIBA 03/2020 - 02/2017
4	Glutamine (L-Glutamine)FDA Link 01/2020 - 01/2018
4	CollagenIBA 10/2019 - 11/2007
4	CateninsIBA 07/2013 - 10/2010
4	Keratins (Keratin)IBA 05/2013 - 10/2003
4	Monoclonal AntibodiesIBA 02/2013 - 04/2004
3	MucinsIBA 07/2020 - 10/2005
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019 - 04/2015
3	Cyclin D1IBA 01/2019 - 04/2008
3	Tumor Biomarkers (Tumor Markers)IBA 12/2017 - 05/2009
3	CalpainIBA 01/2017 - 10/2011
3	RecQ HelicasesIBA 01/2017 - 03/2016
3	Serine (L-Serine)FDA Link 02/2016 - 03/2015
3	Fulvestrant (Faslodex)FDA Link 01/2016 - 07/2007
3	Estrogen Receptor Modulators (Antiestrogen)IBA 12/2015 - 07/2007
3	Protein Isoforms (Isoforms)IBA 03/2015 - 08/2008
3	MicroRNAs (MicroRNA)IBA 01/2013 - 01/2007
3	Epidermal Growth Factor (EGF)IBA 08/2012 - 03/2007
3	Steroid Receptors (Steroid Receptor)IBA 01/2010 - 08/2008
3	Complement System Proteins (Complement)IBA 01/2007 - 07/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2020 - 01/2019
2	TensinsIBA 07/2020 - 02/2011
2	Large Neutral Amino Acid-Transporter 1IBA 02/2020 - 01/2018
2	Dihydrotachysterol (AT 10)IBA 01/2020 - 07/2016
2	zinc-binding protein (zinc binding protein)IBA 01/2019 - 07/2007
2	ThioredoxinsIBA 12/2018 - 08/2011
2	GTP-Binding Proteins (G-Protein)IBA 05/2018 - 04/2015
2	CytokinesIBA 04/2018 - 01/2011
2	Gefitinib (Iressa)FDA Link 01/2018 - 01/2007
2	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 08/2016 - 04/2016
2	taxaneIBA 07/2016 - 04/2013
2	ChromatinIBA 01/2016 - 01/2012
2	Formaldehyde (Formol)FDA Link 01/2016 - 01/2011
2	Peptides (Polypeptides)IBA 05/2015 - 04/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2015 - 07/2007
2	erucylphosphocholineIBA 04/2015 - 08/2012
2	Flap EndonucleasesIBA 12/2014 - 10/2014
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 12/2014 - 05/2014
2	DNA-Activated Protein KinaseIBA 12/2014 - 07/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2014 - 04/2010
2	Methotrexate (Mexate)FDA LinkGeneric 11/2014 - 04/2010
2	IntegrinsIBA 08/2014 - 06/2014

Therapy/Procedure

72	Therapeutics 12/2024 - 10/2005
19	Drug Therapy (Chemotherapy) 10/2022 - 10/2007
9	Radiotherapy 11/2019 - 01/2011
7	Adjuvant Chemotherapy 10/2022 - 10/2007
5	Segmental Mastectomy (Lumpectomy) 01/2019 - 04/2011
4	Neoadjuvant Therapy 01/2021 - 08/2012
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 01/2019
2	Mastectomy (Mammectomy) 11/2019 - 05/2010
2	Ligation 05/2014 - 04/2014